In an intriguing study using genetically engineered mice, this interaction between NRF2 and BRCA1 has been proposed to explain why BRCA1 deficiency results in an increased incidence of breast or ovarian cancers[209]. This evidence concerns the gene NFE2L2 and ovarian cancer.